Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AndoSanTM
- Development stage
- Preclinical
- Lead developer
- Ace Japan
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
AndoSanTM is a proprietary, orally administered liquid mushroom extract primarily composed of Agaricus blazei Murill (AbM) (82.4%), along with Hericium erinaceus (14.7%) and Grifola frondosa (2.9%). [1, 2, 3, 7, 8] It is positioned as a nutraceutical or dietary supplement with immunomodulatory and anti-inflammatory properties. [2] Clinical studies have investigated its potential to alleviate symptoms in patients with inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease. [3, 5] Research suggests it works by reducing levels of various pro-inflammatory cytokines, although the complete mechanism of action is not fully understood. [1] It has also been examined for its effects on cancer-related fatigue and in patients with multiple myeloma. [1, 4, 10] The product was developed by ACE Co. Ltd. in Japan and is commercialized by Immunopharma AS in Norway. [1, 3, 6]
- Brand names
- AndoSanTM
- Other names
- AndoSanTMAndoSan™Agaricus blazei Murill-based mushroom extractAbM-based medicinal mushroom extract
02
Targets
TLR2 (Toll-like Receptor 2)αMβ2 (Integrin αMβ2)CLEC7A (Dectin-1)
Beyond the preview
Go deeper on AndoSanTM.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AndoSanTM.